Biological immortality is no longer a myth.

We are transitioning human biology from a fixed timeline to an iterative software system. Join the closed beta of humanity's next phase.

A
Our Manifesto

We made death a choice.

Biology is the final frontier of engineering. For too long, humanity has accepted decay as an inevitability. We view it as a bug in the code — a collection of mechanical failures that can be diagnosed, treated, and ultimately solved.

Livvay is not just a medical platform; it is a collaborative effort to move beyond the constraints of organic fragility. We believe that with the right data and interventions, time is a variable we can control.

Live forever, or die trying to build the future.

Advanced medical diagnostic chamber

Total biological architecture

Blood, DNA, environment and routine in a single reading

Radical longevity protocol

From daily adjustments to cutting-edge individual bioengineering

Continuous optimization AI

Your body evolves and the protocol evolves with it

A medical operation designed to push life as far as possible

We don't practice reactive medicine. We detect early, correct biological pathways and advance from deep reading to programmable intervention, with the ambition of extending life, function and useful time at the highest possible level.

See the clinical architecture ↗

The engineering of a long life

If there is a real lever to extend life, it's on our radar: deep diagnostics, clinical AI, programmable medicine, individual mRNA vaccines and advanced interventions on pathways like Follistatin, GRIN2B/NMDAR and Klotho.

Your longevity team

Your longevity team

Physicians and specialists build the strategy to protect your body from wear and extend performance with intention.

400+ tests and panels

400+ tests and panels

From blood to genomics, from environment to biological age. We map the body with a depth that almost no one attempts to deliver.

AI-driven action protocol

Your team and our artificial intelligence turn biological data into high-precision daily decisions.

Individual gene therapy and mRNA

mRNA vaccines designed for your genetic profile and precision gene therapies that reprogram risk pathways before they become disease.

Advanced cellular regeneration

Exosomes, IV stem cells and MUSE Cells combined in a biological repair infrastructure for accelerated recovery, tissue rejuvenation and function extension.

Joint preservation

Protocols that sustain cartilage, structural stability and long-term mobility so the body keeps up with the ambition of those who want to live longer and better.

Brain reprogramming

Pathways like GRIN2B/NMDAR to reduce neurotoxicity, increase cognitive plasticity and reverse the neural wear that compromises clarity, memory and decision-making.

Follistatin, Klotho and FOXO3A

Interventions on the pathways that control body composition, cellular senescence, oxidative stress and mineral homeostasis. These are the most direct levers of longevity.

24/7 AI against decline

Every meal, workout and night of sleep becomes data. The AI adapts the protocol in real time so no sign of wear goes unnoticed.

Monthly recalibration

Monthly consultations with your medical team to recalibrate the course, remove bottlenecks and keep pushing your biology forward.

International frontier clinics

Access to partner clinics such as GARM in the Bahamas and Honduras for cutting-edge therapies that don't yet exist in conventional medicine.

Engineering of a long life

Our goal is not just to age better. It's to extend your lifeline with more lucidity, strength and useful time at the highest possible level.

Private Longevity Journey

How it works.

We built a complete clinical journey, from initial screening to individual bioengineering, to turn longevity into a real operation.

01

Apply for entry.

You join the list, go through a private assessment and we determine the level of clinical depth needed for your biology, your current moment and what you want to preserve over time.

02

Complete deep testing.

We execute a complete diagnostic architecture: blood, urine, genetics, biological age, oxygenation, microplastics, environment, imaging, sleep, inflammation and the real context of where you live. We cross-reference signals that a traditional check-up can't even touch with real depth.

03

Build your protocol.

The medical team and clinical AI turn your data into a high-precision personal protocol, with routine, formulas, pharmaceuticals, performance adjustments and programmable medicine when it makes sense for that body.

04

Run the protocol daily.

We monitor your execution in real time to adjust training, sleep, nutrition, recovery and biological response with continuous precision. Each member also receives an exclusive Livvay concierge to personally accompany the protocol throughout the entire journey. The protocol leaves the paper and starts operating in everyday life.

05

Receive your custom supplements.

We ship personalized supplements for the member's daily consumption, from the Livvay Homo Optimus by Biodrops line, designed to work with your genetics, your routine and the lifestyle you want to sustain with consistency.

06

Travel for advanced therapies when needed.

For frontier therapies, the member may travel to our international partner clinics, including the Global Alliance for Regenerative Medicine (GARM), in Paradise Island, Bahamas, or in Roatan, Honduras. This is the context for fronts such as Gene Therapies + mRNA, Regenerative stack, Joint Preservation and Brain RESET, always based on individual eligibility and clinical design.

07

Recalibrate and push further.

We repeat readings, remove bottlenecks and elevate the protocol as your biology responds. This is not a short cycle. It's an architecture for a lifetime, incorporated as a lifestyle, always seeking more time, function and physiological power.

Private member proof

My genetic risk for cancer was 64%. Today my markers are in the control range. No physician had ever even looked at this before.

Livvay Member14 months on protocol64% → control range

Perceived evidence

97%

of members report energy, clarity and vitality that seemed to have been left behind.

See reviews →

Member metric

12 years

was the average reduction in

biological age in the first year of protocol for highly adherent members

Member metric

97%

of members report

energy, clarity and vitality that seemed to have been left behind

Member metric

30x

more biological depth

than traditional preventive medicine typically delivers

*Data based on a limited sample of beta users during the testing phase. Individual results may vary. These numbers do not constitute a guarantee of results and will be updated as the member base grows.

The world's largest testing panel

Over 400 tests, exams and panels integrated into the most ambitious clinical architecture for longevity. Nothing like this exists anywhere in the world to anticipate risk, correct biological pathways and push the human body beyond the common standard.

400+ tests and panels

400+ tests and panels

From complete blood count to genomic analysis. We bring together the greatest diagnostic depth in our category in a single protocol.

Heart & VascularLiver HealthKidney HealthSex HormonesMetabolic HealthNutrientsInflammation
Far beyond the check-up

Far beyond the check-up

Gut microbiome, DNA methylation, telomeres, environmental toxins and oxidative stress. We don't look for the obvious. We look for what changes biological destiny.

Gut MicrobiomeDNA MethylationTelomeresEnvironmental ToxinsOxidative StressBiological Age

Genetics turned into decisions

Over 230 genetic panels to turn predisposition, compatibility and hereditary risk into practical protocol choices.

Genetic PredispositionsNutrient AbsorptionFood SensitivitiesHereditary RisksPharmacogenomicsMetabolism

Environment as a longevity variable

Where you live can accelerate biological decline. We measure air, toxins, radiation and contaminants to remove what is eroding your potential.

Air QualityHeavy MetalsEMF RadiationMold & MycotoxinsWater & Contaminants
Explore by category

No one in the world does what we do at this level

This panel was not created to repeat the traditional check-up. It was created to anticipate risk, correct biological pathways and build the most optimized version of each individual. This is not defensive medicine. It's clinical engineering for radical longevity.

GN

Genetic Tests

234 genetic panels to design a strategy made for your biology, from genetic compatibility to personalized correction of pathways linked to risk, inflammation and aging.

Integrated clinical reading

We create a protocol made for your genetics, not a generic plan.

From genetic compatibility to personalized genetic correction of biological pathways, we use your profile to guide choices tailored to your body.

Genetic compatibility

Shows how your genes tend to respond to nutrients, compounds, pharmaceuticals and interventions.

Targeted genetic correction

Identifies biological pathways that need adjustment to reduce risk, inflammation, aging and performance loss.

Strategy made for the individual

Every protocol decision is born from your genetic signature, not average recommendations for everyone.

Tests and panels

234 exams and panels in this category

Abetalipoproteinemia

Ability to detect floral fragrance

Ability to learn from mistakes

Achilles tendinopathy

Acne

Adult Attention Deficit Hyperactivity Disorder (ADHD)

Age-related macular degeneration

Age-related menopause

Alcohol reaction

Allergen sensitization associated with atopic dermatitis

Alpha-1 Antitrypsin Deficiency (variant PI*S)

Alpha-1 Antitrypsin Deficiency (variant PI*Z)

Alzheimer's

Alzheimer's disease

AMPD enzyme deficiency

Amyotrophic lateral sclerosis

Ankle and knee injuries

Antioxidant capacity

Anxiety

Asthma

Athletic ability

Athletic performance

Atopic dermatitis

Atrial fibrillation

Autism spectrum disorder

Basal cell carcinoma

Baseline cholesterol

Benefit of physical activity in reducing depressive symptoms

Bilirubin levels (African descent populations)

Bitter taste perception

Bladder cancer

Blood pressure reduction in response to physical activity

BMI and waist circumference reduction in response to physical activity

Body mass index (BMI)

Bone density (bone strength)

Breast and ovarian cancer (variant 5382insC)

Breast and ovarian cancer (variant 6174delT)

Breast cancer

Butyrylcholinesterase enzyme deficiency

Caffeine metabolism

Caffeine sensitivity

Calcium levels

Cancer

Cardiorespiratory capacity

Cardiovascular diseases (African descent populations)

Celiac disease

Celiac disease (HLA-DQ2.2 allele)

Celiac disease (HLA-DQ8 allele)

Chronic bronchitis

Chronic kidney disease

Chronic kidney disease (African and African descent populations)

Chronic lymphocytic leukemia

Chronic lymphoid leukemia

Chronic pancreatitis

Cognitive performance

Colorectal cancer

Coronary artery disease

Coronary artery disease (African descent populations)

Creativity

Crohn's disease

Crohn's disease (variant G908R)

Crohn's disease (variant rs11564258)

Cruciate ligament injuries

Detoxification capacity

DHDDS-related autosomal recessive retinitis pigmentosa

Diamine oxidase enzyme deficiency

Dupuytren's disease

Earwax type

Emotional eating

Endometriosis

Energy expenditure

Esophageal and stomach cancer

Essential hypertension

Exercise adherence

Exercise-induced muscle damage

Extreme obesity

Eye color

Eyelid sagging

Facial wrinkles

Factor XII deficiency

Familial hypercholesterolemia

Familial hyperinsulinism

Fat storage

Folate (Vitamin B9 - variant A1298C)

Folate (Vitamin B9 - variant C677T)

Follicle-stimulating hormone (FSH)

Glucose metabolism

Gout

Guillain-Barre syndrome

Hamstring injuries

Heart rate recovery after exercise

Hemochromatosis type 1 (variant C282Y)

Hemochromatosis type 1 (variant H63D)

Hemochromatosis type 1 (variant S65C)

Hereditary amyloidosis (variant T80A)

Hereditary amyloidosis (variant V122I)

Hereditary amyloidosis (variant V50M)

Hereditary fructose intolerance

Hip osteoarthritis

Hodgkin lymphoma

Hostility and euphoria

Hyperactivity

Idiopathic interstitial pneumonias

Impulsivity

Impulsivity (associated with cannabis use)

Inflammation

Inflammatory bowel disease

Intracranial aneurysm

Iron deficiency

Iron deficiency anemia

Iron levels

Iron overload

Knee osteoarthritis

Lactose intolerance

Lactose intolerance (African populations)

LDL levels

Leprosy

Lipedema

Longevity

Low carb diet efficacy

Low fat and high fat diet efficacy

Lung adenocarcinoma

Lung cancer

Maintenance of results after weight loss intervention

Male pattern baldness

Mathematical ability

Mediterranean diet efficacy

Melanoma

Melanoma skin cancer (variant rs137854599)

Melanoma skin cancer (variant rs149617956)

Meningioma

Mental disorders

Metabolic syndrome

Milk protein sensitivity

Multiple sclerosis

Muscle contraction efficiency in response to physical activity

Muscle mass gain

Muscle strength

Muscular endurance

MUTYH-associated polyposis (variant G396D)

Myeloproliferative disorders

Myocardial infarction

Myopia

Non-contact muscle injuries

Non-Hodgkin lymphoma

Non-Hodgkin lymphoma (African populations)

Non-Parkinson essential tremor

Obesity

Obesity (African descent populations)

Obesity risk

Omega-3

Osteoporosis

Osteoporosis (African populations)

Ovarian cancer

Overweight and obesity

Pain sensitivity

Parkinson's disease

Peanut sensitivity

Pendred syndrome

Performance in acceleration and speed activities

Performance in long jump and sprint

Periorbital wrinkles ("crow's feet")

Pharmacogenomics - Acetylsalicylic acid (Aspirin Protect®)

Pharmacogenomics - Acetylsalicylic acid (Aspirin®)

Pharmacogenomics - Atorvastatin (Lipitor®)

Pharmacogenomics - Bisphosphonates

Pharmacogenomics - Hydrochlorothiazide

Pharmacogenomics - Ibuprofen

Pharmacogenomics - Metformin (Glucophage®)

Pharmacogenomics - Nicotine

Pharmacogenomics - Non-steroidal anti-inflammatory drugs

Pharmacogenomics - Omeprazole

Pharmacogenomics - Opioids

Pharmacogenomics - Oral Contraceptives

Pharmacogenomics - Salbutamol (Ventolin®) and Salmeterol (Serevent®)

Pharmacogenomics - Sildenafil (Viagra®)

Pharmacogenomics - Simvastatin (Zocor®)

Pharmacogenomics - Statins

Pharmacogenomics - Sulfonylureas

Pharmacogenomics - Voriconazole

Photoaging

Physical endurance in long-duration activities

Polycystic ovary syndrome

Postpartum weight gain

Predisposition to alcoholism

Predisposition to nicotine dependence

Preference for morning or evening hours

Prostate cancer

Protection against thromboembolic events

Psychotic disorders

Pulmonary arterial hypertension

Recovery time after muscle injury

Reduction of total cholesterol levels in response to exercise

Resistance to antidepressant treatment

Response to antidepressants

Response to ovarian hyperstimulation treatment

Risk of cardiac arrest

Risk of skin hyperpigmentation

Satiety sensation

Saturated fat absorption

Skin cancer

Sleep duration

Sleep intensity

Sleep quality

Snacking behavior throughout the day

Sodium sensitivity

Stomach cancer

Stroke

Sugar intake

Sun sensitivity

Sweet consumption

Systemic lupus erythematosus

Telomere length

THC metabolism (variant rs1057910)

THC metabolism (variant rs1799853)

Thrombophilia (Factor II - Prothrombin)

Thrombophilia (Factor V Leiden)

Thyroid cancer

Triglyceride levels

Type 1 diabetes

Type 2 diabetes

Type 2 diabetes (African populations)

Tyrosinemia type I

Ulcerative colitis

Uterine fibroids

Vitamin A

Vitamin B12

Vitamin B6

Vitamin C

Vitamin D

Vitamin E

Vitamin K

Warrior gene

Wilson's disease

Evidence perceived in the body and over time

When the protocol clicks, time changes direction

These are not reports about generic well-being. These are stories from people who started feeling their body operate with more clarity, energy, recovery and biological control.

R. B.

Public office, member for 14 months

My genetic risk for prostate cancer was 64%. After the full panel and the epigenetic correction protocol, my risk markers dropped to the control range. No physician had ever even looked at this before.

Genetic cancer risk from 64% down to control range

Apply to the waitlist →

-12 years

of biological age in 14 months on protocol

64% → 3%

reduction in oncological risk score

234

genetic panels cross-referenced in protocol

J. K.

Private equity, USA

My biological age was 53 at 41. In 6 months on the protocol it dropped to 38. My cardiologist asked to see the labs because he couldn't believe the numbers.

Biological age from 53 to 38 in 6 months

K. M.

Financial executive, USA

They found an MTHFR mutation that explained 9 years of chronic fatigue. They changed my entire supplementation and within 3 weeks I already felt like a different person.

Genetic mutation found after 9 years without diagnosis

M. S.

Tech industry, USA

My ApoB was at 148 and no one had ever ordered it. Livvay identified silent cardiovascular risk, adjusted the protocol, and in 4 months it dropped to 62. They literally prevented a cardiac event.

ApoB from 148 to 62, cardiovascular risk eliminated

E. R.

Entertainment industry, USA

My telomeres were shortened like someone 15 years older. After the protocol with FOXO3A activation and oxidative stress correction, my epigenetic age dropped 9 years in the second cycle.

Epigenetic age decreased 9 years with telomere correction

F. P.

C-level, Brazil

Tinha inflamação crônica silenciosa com PCR ultra em 8.4 e ninguém conectava com meu histórico familiar de Alzheimer. O protocolo reduziu para 0.3 e ativou rotas neuroprotetoras que eu nem sabia que existiam.

CRP from 8.4 to 0.3, neuroprotective protocol activated

Important questions

When the mission is to live longer, the questions level up

We are not selling convenience. We are proposing a new relationship with time, risk, body and future.

No. A check-up looks backward. Livvay looks forward. It's a continuous clinical architecture that detects risk before symptoms appear, corrects biological pathways in real time and builds a protocol that evolves with your body.

Livvay was designed for those who want to operate before collapse. The earlier you join, the more room there is to preserve performance, lucidity and useful time. If a condition already exists, the protocol can help manage it more intelligently, but the greatest value lies in anticipation.

Aging is not a passive destiny. It is a biological process that can be measured, attacked, slowed and reorganized with precision. Livvay exists to turn radical longevity into a real, daily and personal operation.

Complete mapping with 400+ tests and panels, 234 genetic panels, individualized protocol with AI, dedicated medical team, exclusive concierge, personalized Livvay Homo Optimus supplementation and access to frontier therapies at international partner clinics.

The Livvay membership starts at US$ 1,000,000 per year per individual. The price reflects the clinical depth, the dedicated team, the tests, the frontier therapies and the continuous protocol involved. We offer special conditions for families and partnerships. Details are presented during the private assessment.

These are interventions such as gene therapy, individual mRNA, stem cells, exosomes, MUSE Cells and joint preservation protocols. Performed at international partner clinics such as GARM in the Bahamas and Honduras, according to individual clinical eligibility.

You apply to the waitlist, go through a private assessment and, if approved, your medical team initiates the complete mapping. There is no automatic entry. Each member is individually evaluated.

Results vary from person to person. No protocol represents a guarantee of benefit, prevention or life extension. What we guarantee is the depth of reading, the precision of clinical engineering and the commitment of a team that operates at the limit of what science allows.

Sample collections are performed by Livvay partner clinics present in most Brazilian state capitals. Our operation currently serves Brazil and the United States exclusively. For advanced frontier therapies, the member travels to international partner clinics with all logistics organized by the Livvay concierge.

What comes next

The future of longevity is being built right now

Each phase represents a leap in precision, personalization and the reach of what human biology can become.

Phase 01Live
2024

Clinical foundation

Complete mapping with 400+ tests, 234 genetic panels, AI-powered individualized protocol and dedicated medical team. The foundation that lets us see what no one else sees.

Complete genetic and epigenetic mapping
Personalized supplementation protocol
1:1 dedicated concierge and medical team
Active operation in Brazil and USA
Phase 02Live
2025

Predictive intelligence

Proprietary AI engine that cross-references genetic, epigenetic, blood and environmental data to predict risks years in advance and recalibrate protocols in real time.

Predictive engine with proprietary ML
Real-time risk dashboard for members
Automatic protocol recalibration
Advanced wearable integration
Phase 03Live
2025–2026

Frontier therapies

Expanded access to individualized gene therapies, personalized mRNA, next-gen stem cells and cellular reprogramming protocols at international partner clinics.

Individualized gene therapy
Personalized mRNA by genetic profile
Cellular reprogramming protocol (Yamanaka)
Expanded international clinic network
Biodrops launch (biodrops.com.br)
Phase 04Next
2027

Livvay Health Centers

Proprietary longevity centers with full clinical infrastructure, cutting-edge technology and resident medical teams. The physical environment where each member's biology is monitored and optimized in person.

Livvay Health Center São Paulo
Livvay Health Center Rio de Janeiro
Livvay Health Center Brasília (DF)
Basic plan launch accessible to all audiences
Phase 05Vision
2027–2028

Life Foundation

Creation of a global foundation dedicated to funding longevity research, programs and initiatives worldwide. Open science, expanded access and impact beyond members.

Life Foundation established
Global funding for longevity projects
Research fellowship programs
Partnerships with universities and research institutes
Phase 06Vision
2028–2030

Radical longevity

The ultimate goal: turning aging into a controllable variable. Organs on demand, preventive gene editing and protocols that redefine the biological limits of human time.

Tissue and organ bioprinting
Precision preventive gene editing
Advanced cellular cryopreservation
Radical healthspan extension protocol
Phase 07Vision
2030+

Global scale and capital markets

Over $1 billion invested in longevity research. IPO on the NYSE and consolidation of Livvay as the global reference in human life extension.

Over $1 billion invested in longevity research
IPO on the NYSE (New York Stock Exchange)
Expansion to all continents
Global reference in precision longevity
Apply
Entry by application

The next phase of your life doesn't have to look like the last one

We are opening access for those who have decided to treat their own biology as a serious long-term project. Few get in. Those who do, enter to live with more time, more clarity and more power.

8

Homo Optimus

BR + US

Active operation

1:1

Dedicated team

Apply to the waitlist

Fill in your details. If your profile is eligible, we will reach out for the private assessment.

By applying you agree to our privacy policy. Your data is protected and never shared.

Livvay
About our context

We made death a choice.

Which path do you want to follow?

Livvay was designed for those who refuse to age on autopilot. We map risk, anticipate decline and turn longevity into a practical, daily and personal decision.

© 2026 Livvay Health Int. All rights reserved.

Livvay is a longevity and advanced medicine platform. Some of the protocols, strategies and therapies discussed on our platform may involve investigational approaches, including regenerative medicine and gene therapy, that have not been approved by the FDA or Anvisa for broad clinical use.

Results vary from person to person. No content, recommendation or protocol represents a guarantee of benefit, prevention, reversal of a clinical condition or life extension. Every decision must consider individual assessment, clinical eligibility, risks, contraindications and professional monitoring.